Medifast Stock Price and Value Analysis

Should you buy Medifast stock? (NYSE:MED). Let's see how it does in our automated value investing analysis system.

  • This company has a large dividend yield!
  • This company is solid.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This stock looks overpriced.

Inside the MED Numbers

MED Price
(Medifast stock price per share)
[?] MED Fair Price
(based on intrinsic value)
[?] MED Safety Price (based on a variable margin of safety) $17.77
[?] PE Ratio versus Sector 5% lower than other Consumer Goods stocks
[?] PE Ratio versus Industry 34% lower than other Personal Services stocks
[?] Cash Yield 2.54%
[?] Free Cash Flow Jitter 82%
[?] Dividend Yield 6%
Shares Shorted 617,807

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 617,807 shares shorted. With 10,020,265 shares available for purchase and an average trading volume over the past 10 trading days of 119,190, it would take at least 5.183 days for all of the short holders to cover their shorts.

Is Medifast Stock on Sale?

We believe that Medifast may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Medifast looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy MED Stock?

Does Medifast have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.